The Attention-Deficit Hyperactivity Disorder (ADHD) therapeutics market value will rise from $6.9 billion in 2013 to $9.9 billion by 2020, with broadening diagnostic criteria a key driver of growth, according to business intelligence provider GBI Research.

The company’s latest report, ADHD Therapeutics to 2020 – Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations, states that this increase, which represents a Compound Annual Growth Rate (CAGR) of 5.3% and relates to eight major markets (the US,

 » Read more about: ADHD Treatment Market Value to Reach $9.9 Billion  »